Nelsen Robert

Nelsen Robert is listed in public filings as director, 10 percent owner:. This Nelsen Robert insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Sana Biotechnology, Inc. (SANA), Prime Medicine, Inc. (PRME), and Lyell Immunopharma, Inc. (LYEL). Investors use Nelsen Robert's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.